2 results
Approved WMOCompleted
To confirm previous study results using a Solace Balloon and to support future marketing efforts in the European Union and provide data for publications.
Approved WMOCompleted
To assess indacaterol (300 and 600 ug once daily via SDDPI) superiority in patients with COPD as compared to placebo with respect to 24 h post dose (through) FEV1 after 12 weeks of treatment.